Graf Akcie CLVS (Clovis Oncology Inc). Diskuze k akciím CLVS. Aktuální informace CLVS.

Základní informace o společnosti Clovis Oncology Inc (Akcie CLVS)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 460.09M
Hodnota podniku (EV) 943.01M
Tržby 156.944M
EBITDA -245.55
Zisk -310.36
Růst v tržbách Q/Q -7.69 %
Růst v tržbách Y/Y -1.52 %
P/E (Cena vůči ziskům) N/A
Forward P/E -0.02
EV/Sales 6.01
EV/EBITDA N/A
EV/EBIT N/A
PEG N/A
Price/Sales 2.88
P/FCF N/A
Price/Book -2.85
Účetní hodnota na akcii -1.55
Hotovost na akcii 2.34
FCF vůči ceně -48.58 %
Počet zaměstnanců 429
Tržba na zaměstnance 365.837k
Profit margin -224.41 %
Operating margin -161.28 %
Gross margin 74.89 %
EBIT margin -178.36 %
EBITDA margin -156.45 %
EPS - Zisk na akcii N/A
EPS - Kvartální růst -46.96 %
EPS - Očekávaný růst příští rok -44.94 %
Return on assets -53.52 %
Return on equity 165.49 %
ROIC -53.21 %
ROCE -70.27 %
Dluhy/Equity -4.81
Čistý dluh/EBITDA -7.06
Current ratio 1.70
Quick Ratio 0.96
Volatilita 4.51
Beta 1.09
RSI 45.27
Cílová cena analytiků 7
Známka akcie (dle analytiků) 3.43
Insider ownership 1.84 %
Institutional ownership 50.42 %
Počet akcií 118.41M
Procento shortovaných akcií 30.23 %
Short ratio 7.42 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2011
Země United States

Finanční výsledky akcie CLVS

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$143.006$95.388$55.511$0.078-$13.625
Cost Of Goods Sold$34.686$22.074$11.737$0.07--
Gross Profit$108.32$73.314$43.774$0.008-$13.625
Research And Development Expenses$283.146$231.347$142.498$251.129$269.251$137.705
SG&A Expenses$182.769$175.781$138.907$40.731$30.524$21.457
Other Operating Income Or Expenses$-9.711-----
Operating Expenses$519.752$429.202$293.142$372.811$376.721$172.084
Operating Income$-376.746$-333.814$-237.631$-372.733$-376.721$-158.459
Total Non-Operating Income/Expense$-21.88$-33.587$-112.344$-8.438$-5.216$0.736
Pre-Tax Income$-398.626$-367.401$-349.975$-381.171$-381.937$-157.723
Income Taxes$1.798$0.608$-3.578$-32.034$-29.076$2.308
Income After Taxes$-400.424$-368.009$-346.397$-349.137$-352.861$-160.031
Other Income------
Income From Continuous Operations$-400.424$-368.009$-346.397$-349.137$-352.861$-160.031
Income From Discontinued Operations------
Net Income$-400.424$-368.009$-346.397$-349.137$-352.861$-160.031
EBITDA$-367.641$-325.69$-233.494$-265.622$-283.798$-154.238
EBIT$-376.746$-333.814$-237.631$-372.733$-376.721$-158.459
Basic Shares Outstanding545247383634
Shares Outstanding545247383634
Basic EPS$-7.43$-7.07$-7.36$-9.07$-9.79$-4.72
EPS - Earnings Per Share$-7.43$-7.07$-7.36$-9.07$-9.79$-4.72
# 2020 2019 2018 2017 2016 2015
Current Ratio2.75374.55117.69094.25957.141210.2816
Long-term Debt / Capital1.34470.79710.43441.01310.48210.4566
Debt/Equity Ratio-3.90083.9290.7682-77.35990.93090.8403
Gross Margin75.745176.858778.856510.2564-100
Operating Margin-263.4477-349.9539-428.0791-477862.8--1163.002
EBIT Margin-263.4477-349.9539-428.0791-477862.8--1163.002
EBITDA Margin-257.0808-341.4371-420.6266-340541--1132.022
Pre-Tax Profit Margin-278.7477-385.1648-630.4606-488680.8--1157.6
Net Profit Margin-280.005-385.8022-624.015-447611.5--1174.539
Asset Turnover0.21360.11050.07550.0002-0.0175
Inventory Turnover Ratio1.3080.81540.4267---
Receiveable Turnover6.95497.40078.98090.6446--
Days Sales In Receivables52.481249.319540.6418566.218--
ROE - Return On Equity229.7896-251.254-94.22289607.304-117.3661-48.2559
Return On Tangible Equity133.3631-1169.582-122.4632426.4373-252.3627-303.8083
ROA - Return On Assets-59.8001-42.6153-47.1141-95.7702-49.4629-20.5858
ROI - Return On Investment-79.2158-50.9751-53.2884-125.8188-60.782-26.2213
Book Value Per Share-3.17082.77417.2706-0.09387.83789.7604
Operating Cash Flow Per Share1.0225-1.48391.38510.0938-3.5705-0.9529
Free Cash Flow Per Share1.144-1.59761.33950.1599-3.5874-1.0161

Porovnání s konkurencí: Akcie CLVS

Společnost P/E PEG Růst v tržbách (roční) Růst v EPS Return on equity P/B Profit margin
CLVS N/A N/A -1.52 % -44.94 % 165.49 % -2.85 -224.41 %
Akcie ABBV 30.30 1.28 48.31 % 14.49 % 48.79 % 14.98 10.08 %
Akcie AZN 42.09 1.02 14.90 % 40.43 % 26.02 % 10.28 11.81 %
Akcie BMRN 16.70 2.77 3.76 % -105.99 % 20.22 % 3.43 46.18 %
Akcie JNJ 23.88 1.67 10.79 % 7.27 % 27.01 % 6.71 17.82 %
Akcie LLY 35.43 1.63 16.46 % 27.92 % 101.98 % 39.72 25.24 %
Akcie PFE 17.66 1.97 4.96 % 50.00 % 19.81 % 3.72 22.95 %

Nedávné obchody insiderů: Akcie CLVS

Jméno Obchod Cena Objem
Thomas C. Harding
See Remarks
Option
3 Dec 2020
$5.41 $2,916
Gillian C Ivers Read
See Remarks
Option
10 Dec 2020
$3.28 $226,205
Lindsey Rolfe
See Remarks
Option
15 Dec 2020
$3.28 $56,550
Gillian C Ivers Read
See Remarks
Option
21 Dec 2020
$5.25 $9,834
Lindsey Rolfe
See Remarks
Option
21 Dec 2020
$5.25 $18,032
Gillian C Ivers Read
See Remarks
Option
1 Feb 2021
$8.46 $188,235
Lindsey Rolfe
See Remarks
Option
1 Feb 2021
$8.46 $188,235
Daniel W Muehl
See Remarks
Option
1 Feb 2021
$8.46 $204,098
Paul Edward Gross
See Remarks
Option
1 Feb 2021
$8.46 $204,098
Thomas C. Harding
See Remarks
Option
1 Feb 2021
$8.46 $74,558
Thomas C. Harding
See Remarks
Option
1 Feb 2021
$8.46 $16,709
Thomas C. Harding
See Remarks
Option
3 Dec 2020
$5.41 $2,916
Gillian C Ivers Read
See Remarks
Option
10 Dec 2020
$3.28 $226,205
Lindsey Rolfe
See Remarks
Option
15 Dec 2020
$3.28 $56,550
Gillian C Ivers Read
See Remarks
Option
21 Dec 2020
$5.25 $9,834
Lindsey Rolfe
See Remarks
Option
21 Dec 2020
$5.25 $18,032
Gillian C Ivers Read
See Remarks
Option
1 Feb 2021
$8.46 $188,235
Lindsey Rolfe
See Remarks
Option
1 Feb 2021
$8.46 $188,235
Daniel W Muehl
See Remarks
Option
1 Feb 2021
$8.46 $204,098
Paul Edward Gross
See Remarks
Option
1 Feb 2021
$8.46 $204,098
Thomas C. Harding
See Remarks
Option
1 Feb 2021
$8.46 $74,558
Thomas C. Harding
See Remarks
Option
1 Feb 2021
$8.46 $16,709

Diskuze k akciím CLVS